Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

BACKGROUND: NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD, in line with highly prevalent dyslipidemia in this population. Increased plasma triglyceride (TG)‐rich lipoprotein (TRL) concentrations, an importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Deprince, Audrey, Hennuyer, Nathalie, Kooijman, Sander, Pronk, Amanda C. M., Baugé, Eric, Lienard, Viktor, Verrijken, An, Dirinck, Eveline, Vonghia, Luisa, Woitrain, Eloïse, Kloosterhuis, Niels J., Marez, Eléonore, Jacquemain, Pauline, Wolters, Justina C., Lalloyer, Fanny, Eberlé, Delphine, Quemener, Sandrine, Vallez, Emmanuelle, Tailleux, Anne, Kouach, Mostafa, Goossens, Jean‐Francois, Raverdy, Violeta, Derudas, Bruno, Kuivenhoven, Jan Albert, Croyal, Mikaël, van de Sluis, Bart, Francque, Sven, Pattou, François, Rensen, Patrick C. N., Staels, Bart, Haas, Joel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Steatohepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026963/
https://www.ncbi.nlm.nih.gov/pubmed/35735979
http://dx.doi.org/10.1002/hep.32631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026963/
https://www.ncbi.nlm.nih.gov/pubmed/35735979
http://dx.doi.org/10.1002/hep.32631

Ejemplares similares